This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Karen Hinsinger
Introduction
Karen Hinsinger is a notable inventor based in Massy, France. She has made significant contributions to the field of medical science, particularly in the treatment of infections. Her work has led to the development of innovative solutions that address critical health issues.
Latest Patents
One of her key patents is titled "Quinazolinone derivatives for use in the treatment of chlamydiales infections." This invention relates to a method for treating a Chlamydiae infection by administering a therapeutically effective amount of a compound of formula (I) to a subject in need thereof. The specific details of the compound are defined in the claims of the patent. Karen holds 1 patent in this area, showcasing her expertise and dedication to advancing medical treatments.
Career Highlights
Karen is affiliated with the Commissariat à l'Énergie Atomique et aux Énergies Alternatives, a prominent research institution in France. Her role there has allowed her to engage in groundbreaking research and development, contributing to the advancement of medical science. Her innovative approach and commitment to her work have made her a respected figure in her field.
Collaborations
Throughout her career, Karen has collaborated with talented individuals such as Daniel Gillet and Julien Barbier. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Karen Hinsinger's contributions to the field of medical science through her innovative patents and collaborations highlight her importance as an inventor. Her work continues to pave the way for advancements in the treatment of infections, making a significant impact on public health.